Replies to post #4556 on Gilead Sciences Inc (GILD)

[BottomBounce]

$GE investors received good news on the vaccine front late Thursday, as the Food and Drug Administration approved the first COVID-19 treatment (https://marketwatch.com/story/gileads-stock-rises-as-fda-formally-approves-remdesivir-2020-10-22), Gilead Sciences Inc.'s $GILD Veklury, for patients who have been hospitalized with COVID-19 infections.